麦澜德(688273) - 投资者关系活动记录表（2024年7月2日）

Group 1: Company Overview and Business Focus - Nanjing Maillande Medical Technology Co., Ltd. focuses on women's health and beauty through physical rehabilitation interventions, providing comprehensive solutions from prevention to rehabilitation for common diseases in women's life cycles [3]. - The company was selected as a "Manufacturing Industry Single Champion Enterprise" by the Ministry of Industry and Information Technology in March 2024 [3]. - Maillande's product offerings are based on five technology platforms: sound, light, electricity, heat, and magnetism, targeting women's health and beauty needs [3]. Group 2: Product Development and Innovations - In March 2024, the company launched the "Magnetic Electric Thermal Shadow · Smart Integration PI-ONE" intelligent pelvic floor diagnosis and treatment system, enhancing its product solutions from basic offerings to scenario-based solutions [4][5]. - The new product integrates pelvic structure and function information, utilizing big data algorithms to assist physicians in matching personalized treatment plans [5]. - The company has completed acquisitions, including 100% of Aotong Laser and 55% of Xiaofu Technology, to drive rapid development in the reproductive anti-aging sector [4][5]. Group 3: Market Strategy and Sales Approach - The company employs a "mainly distribution, supplemented by direct sales" model, implementing a strategic business unit (SBU) structure to enhance sales efficiency and profitability [6]. - Sales efforts are prioritized in core customer segments, with incentive policies in place to promote new products [6]. - The company is actively expanding its market presence in the reproductive anti-aging sector, responding to increasing demand due to earlier onset of menopause symptoms among women [7][8]. Group 4: Financial Performance and Investor Relations - The company plans to repurchase shares using its own funds, with a total repurchase amount between RMB 20 million and RMB 40 million [9]. - A mid-year dividend proposal suggests distributing cash dividends of RMB 4.00 per 10 shares to all shareholders [9]. - The management emphasizes long-term development and sustainable returns for investors, with ongoing efforts to improve operational efficiency and profitability [8][9].